SSA
GWPH

Schonfeld Strategic Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,000
Closed -$217K – 2540
2021
Q1 		$217K Sell
1,000
-9,800
-91% -$1.84M ﹤0.01% 1467
2020
Q4 		$1.25M Buy
10,800
+8,100
+300% +$907K 0.02% 736
2020
Q3 		$263K Sell
2,700
-10,905
-80% -$1.25M 0.01% 1133
2020
Q2 		$1.67M Buy
+13,605
New +$1.54M 0.04% 455
2020
Q1 		– Sell
-20,900
Closed -$2.19M – 1673
2019
Q4 		$2.19M Sell
20,900
-13,200
-39% -$1.48M 0.05% 325
2019
Q3 		$3.92M Buy
34,100
+16,800
+97% +$2.55M 0.12% 195
2019
Q2 		$2.98M Sell
17,300
-66,500
-79% -$11.5M 0.11% 228
2019
Q1 		$14.1M Buy
83,800
+8,100
+11% +$1.21M 0.49% 42
2018
Q4 		$7.37M Sell
75,700
-5,000
-6% -$656K 0.28% 86
2018
Q3 		$13.9M Sell
80,700
-900
-1% -$130K 0.62% 22
2018
Q2 		$11.4M Buy
81,600
+19,329
+31% +$2.75M 0.62% 15
2018
Q1 		$7.02M Sell
62,271
-19,182
-24% -$2.41M 0.53% 34
2017
Q4 		$10.8M Buy
81,453
+52,049
+177% +$6.12M 0.88% 7
2017
Q3 		$2.98M Sell
29,404
-35,151
-54% -$3.76M 0.27% 117
2017
Q2 		$6.47M Buy
64,555
+11,928
+23% +$1.28M 0.67% 23
2017
Q1 		$6.37M Buy
52,627
+22,301
+74% +$2.74M 0.64% 29
2016
Q4 		$3.39M Buy
30,326
+22,822
+304% +$2.75M 0.44% 56
2016
Q3 		$997K Buy
+7,504
New +$717K 0.17% 176

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Schonfeld Strategic Advisors's GWPH Position: Q2 2021 in Review

Schonfeld Strategic Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,000 shares — an estimated $217K sold.

Schonfeld Strategic Advisors first reported a position in GWPH in Q3 2016 and held it in 18 quarters. The position peaked at $14.1M in Q1 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Schonfeld Strategic Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 1,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $217K.
  • Schonfeld Strategic Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2016 and held it in 18 quarters.
  • Schonfeld Strategic Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $14.1M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.